Liverpool Women's NHS Foundation Trust runs Liverpool Women's Hospital, a major obstetrics, gynaecology and neonatology research hospital in Liverpool, England.

During the past decade, Liverpool Women's Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 2 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Liverpool Women's Hospital" #1 sponsor was "Liverpool Women's NHS Foundation Trust" with 5 trials, followed by "Bayer" with 3 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored, "St George's, University of London" with 2 trials sponsored and "Thayyil, Sudhin" with 2 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Liverpool Women's Hospital" #1 collaborator was "Liverpool Women's NHS Foundation Trust" with 4 trials as a collaborator, "University of Liverpool" with 3 trials as a collaborator, "Birmingham Women's NHS Foundation Trust" with 2 trials as a collaborator, "Oxford University Hospitals NHS Trust" with 2 trials as a collaborator and "The Leeds Teaching Hospitals NHS Trust" with 2 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 56 trials.

According to Clinical.Site data, the most researched conditions in "Liverpool Women's Hospital" are "Fallopian Tube Cancer" (3 trials), "Ovarian Cancer" (3 trials), "Primary Peritoneal Cavity Cancer" (3 trials), "Hot Flashes" (2 trials) and "Immune System and Related Disorders" (2 trials). Many other conditions were trialed in "Liverpool Women's Hospital" in a lesser frequency.

Most popular intervention types in "Liverpool Women's Hospital" are "Drug" (13 trials), "Device" (7 trials), "Other" (7 trials), "Procedure" (5 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Arginine" (3 trials), "Elinzanetant (BAY3427080)" (2 trials), "Questionnaire" (2 trials) and "carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Liverpool Women's Hospital" are 22 trials for "Female" genders and 12 trials for "All" genders.

Currently, there are NaN active trials in "Liverpool Women's Hospital". 1 are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Liverpool Women's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Liverpool Women's Hospital, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 10 trials that are defined as “Not Applicable".